scholarly journals Colchicine as a Potential Treatment Choice for COVID-19 Patients in Developing Countries: COVID-19 and Colchicine

2022 ◽  
Vol 29 (1) ◽  
pp. 56-57
Author(s):  
Byeongzu Ghang ◽  
Jinseok Kim
Author(s):  
Ekta Khare ◽  
Sandeep Pandey ◽  
Ritesh Kumar

Covid sickness 2019 (COVID‐19) flare-up is a continuous pandemic brought about by serious intense respiratory condition Covid 2 (SARS‐CoV‐2) with impressive mortality around the world. The fundamental clinical indication of COVID‐19 is the presence of respiratory side effects; however a few patients create extreme cardiovascular and renal inconveniences. There is desperation to comprehend the instrument by which this infection causes difficulties to create treatment choices. Curcumin, a characteristic polyphenolic compound, could be a potential treatment choice for patients with Covid infection. In this examination, we audit a portion of the likely impacts of curcumin, for example, repressing the section of infection to the phone, restraining epitome of the infection and viral protease, just as tweaking different cell flagging pathways. This survey gives a premise to additional innovative work of clinical utilizations of curcumin for the treatment of recently arose SARS‐CoV‐2.


Sign in / Sign up

Export Citation Format

Share Document